Editorial Type:
Article Category: Other
 | 
Online Publication Date: Jan 01, 2018

Anesthetic Considerations for Patients on Antidepressant Therapy – Part II

DMD,
MD, and
DMD, MS, PhD
Page Range: 60 – 65
DOI: 10.2344/anpr-65-01-10
Save
Download PDF

Millions of patients take antidepressant medications in the United States for the treatment of depression or anxiety disorders. Some antidepressants are prescribed off-label to treat problems such as chronic pain, low energy, and menstrual symptoms. Antidepressants are a broad and expansive group of medications, but the more common drug classes include tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and monoamine oxidase inhibitors. A miscellaneous or “atypical” category covers other agents. Some herbal supplements that claim to have antidepressant activity will also be discussed. Part I of this series reviewed antidepressant pharmacology, adverse effects, and drug interactions with adrenergic agonists. In part II, drug–drug interactions with sedation and general anesthetics, bleeding effects, and serotonin syndrome will be discussed.

  • Download PDF
Copyright: © 2018 by the American Dental Society of Anesthesiology
<bold>Figure 1</bold>
Figure 1

Analgesic prodrugs, codeine and tramadol, require metabolism by CYP 2D6 to their active metabolites, morphine and o-desmethyltramadol, respectively. CYP2D6 inhibition by SSRIs (fluoxetine, paroxetine) may result in inadequate analgesia. From Hersh EV, Moore PA. JADA. 2004;135:298–311.


<bold>Figure 2</bold>
Figure 2

Increased risk of bleeding with selective serotonin reuptake inhibitors (SSRIs) and nonsteroidal anti-inflammatory drug (NSAIDs). Pinto A, Farrar JT, Hersh EV. Compend Contin Educ Dent. 2009;30:142–151.


Contributor Notes

Address correspondence to Mana Saraghi, DMD, Dental Anesthesiology Residency Program, Jacobi Medical Center, 1400 Pelham Parkway South, Building 1, Suite 3NE1, Bronx, New York 10461; msaraghi@gmail.com.
Received: Dec 11, 2017
Accepted: Dec 13, 2017